Incorporate sample size proportionate with each indication: CDSCO Panel Tells Sun Pharma on Ranibizumab study Dr. Divya Colin3 Jun 2024 6:00 PM ISTNew Delhi: Reviewing the proposal for conducting the Phase IV study of Ranibizumab Solution for Injection 10 mg/mL, the Subject Expert Committee (SEC)...
NPPA Revises Ceiling Price of FDC Budesonide Plus Formoterol Inhalation Dr. Divya Colin2 Jun 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Department of...
CDSCO Panel approves AstraZeneca Pharma's Benralizumab solution for Injection in auto-injector Dr. Divya Colin1 Jun 2024 6:00 PM ISTNew Delhi: Granting the local phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct BE study: CDSCO Panel Tells Sun Pharma Labs on COPD drug Umeclidinium powder for inhalation Dr. Divya Colin31 May 2024 6:00 PM ISTNew Delhi: In line with the proposal to manufacture and market Umeclidinium powder for inhalation 62.5mcg, the Subject Expert Committee (SEC)...
Drug Alert: 50 Drug Samples including Macleods' THYROX75 Fail To Qualify CDSCO Test Dr. Divya Colin30 May 2024 6:00 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 50 medicine...
Novartis Gets CDSCO Panel Nod to Study Iptacopan in Atypical Hemolytic Uremic Syndrome Dr. Divya Colin29 May 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA Fixes Retail Prices Of 4 Formulations, Details Dr. Divya Colin28 May 2024 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of retail prices of 4...
AstraZeneca Pharma India Gets CDSCO Panel Nod To Import, Market Eculizumab for Atypical hemolytic uremic syndrome Dr. Divya Colin27 May 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca Pharma India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
NPPA Fixes Ceiling price Of 6 Scheduled Formulations, Details Dr. Divya Colin26 May 2024 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of...
Johnson and Johnson Gets CDSCO Panel Nod For Additional Indication of Daratumumab to Treat Light chain AL amyloidosis Dr. Divya Colin25 May 2024 6:00 PM ISTNew Delhi: Granting local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
NPPA Fixes Retail Price Of 37 Formulations, Details Dr. Divya Colin24 May 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 37 formulations under the...
Discontinue Olaparib Tablets Marketing For Specific Cancers: CDSCO Dr. Divya Colin23 May 2024 6:00 PM ISTNew Delhi: In a recent notification, the Central Drugs Standard Control Organisation (CDSCO) has directed all manufacturers of the anticancer...
